BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23400943)

  • 1. Neurogenetic disorders and treatment of associated seizures.
    Faulkner MA; Singh SP
    Pharmacotherapy; 2013 Mar; 33(3):330-43. PubMed ID: 23400943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine therapy of epilepsy with Angelman's syndrome.
    Dion MH; Novotny EJ; Carmant L; Cossette P; Nguyen DK
    Epilepsia; 2007 Mar; 48(3):593-6. PubMed ID: 17326790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus in Angelman syndrome.
    Pollack SF; Grocott OR; Parkin KA; Larson AM; Thibert RL
    Epilepsy Behav; 2018 May; 82():170-174. PubMed ID: 29555100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
    van der Poest Clement EA; Sahin M; Peters JM
    J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital.
    Shaaya EA; Grocott OR; Laing O; Thibert RL
    Epilepsy Behav; 2016 Jul; 60():138-141. PubMed ID: 27206232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
    Humphrey A; Neville BG; Clarke A; Bolton PF
    Dev Med Child Neurol; 2006 Jul; 48(7):609-11. PubMed ID: 16780633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; GuardalĂ  C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.
    Valente KD; Koiffmann CP; Fridman C; Varella M; Kok F; Andrade JQ; Grossmann RM; Marques-Dias MJ
    Arch Neurol; 2006 Jan; 63(1):122-8. PubMed ID: 16401744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A "happy" toddler presenting with sudden, life-threatening seizures.
    Stein D; Chetty M; Rho JM
    Semin Pediatr Neurol; 2010 Mar; 17(1):35-8. PubMed ID: 20434691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
    Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
    Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D; Bogner M; Parker-Menzer K; Devinsky O
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
    Thibert RL; Conant KD; Braun EK; Bruno P; Said RR; Nespeca MP; Thiele EA
    Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.
    Lopez JC; Pare JR; Blackmer AB; Orth LE
    J Pediatr Health Care; 2022; 36(5):479-488. PubMed ID: 35987555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies.
    Mudigoudar B; Weatherspoon S; Wheless JW
    Semin Pediatr Neurol; 2016 May; 23(2):167-79. PubMed ID: 27544474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex.
    Whitney R; Jan S; Zak M; McCoy B
    Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.